Bone resorptive activity of osteoclast-like cells generated in vitro by PEG-induced macrophage fusion

Murillo, Andrea; Guerrero, Carlos A; Acosta, Orlando; Cardozo, Carmen A.
Biol. Res ; 43(2): 205-224, 2010. ilus
Artículo en Inglés | LILACS | ID: lil-567536

Documentos relacionados

  1. Destruxin E backbone modification effects on osteoclast Morphology: Synthesis and SAR study of N-Desmethyl and N-Methyl analogs.
  2. Bone resorptive activity of osteoclast-like cells generated in vitro by PEG-induced macrophage fusion.
  3. Diterpenoids from the Whole Plants of Ajuga nipponensis and Their Inhibition of RANKL-Induced Osteoclastogenesis.
  4. Macrophage colony-stimulating factor pretreatment of bone marrow progenitor cells regulates osteoclast differentiation based upon the stage of myeloid development.
  5. TGF-ß Negatively Regulates Mitf-E Expression and Canine Osteoclastogenesis.
  6. Alpha-1 antitrypsin inhibits RANKL-induced osteoclast formation and functions.
  7. Fructose 1,6-bisphosphate inhibits osteoclastogenesis by attenuating RANKL-induced NF-κB/NFATc-1.
  8. FTY-720P Suppresses Osteoclast Formation by Regulating Expression of Interleukin-6 (IL-6), Interleukin-4 (IL-4), and Matrix Metalloproteinase 2 (MMP-2).
  9. 3',4',7,8-Tetrahydroxyflavone inhibits RANKL-induced osteoclast formation and bone resorption.
  10. Involvement of CX3CL1 in the Migration of Osteoclast Precursors Across Osteoblast Layer Stimulated by Interleukin-1ß.